Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ciitizen

Explore full profile

Ciitizen's mission is empower patients with complete control of their health data

Redwood City, United StatesFounded 2017Health Tech & Medtech
Valuation $250–500M Last recorded · 2021
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Ciitizen and the history behind them.

About Ciitizen

Ciitizen operates in the digital health sector, providing a platform that allows patients to collect, organize, and share their medical records. The company primarily serves individuals dealing with serious health conditions, starting with cancer patients. By enabling users to upload their health documents, Ciitizen transforms this data into a structured digital profile that can be shared with healthcare providers, caregivers, and researchers. This service is offered free of charge to users, making it accessible to a broad audience. The business model is centered around partnerships with healthcare organizations and research institutions, which benefit from access to aggregated, anonymized health data for clinical trials and research purposes. Ciitizen generates revenue through these partnerships and potentially through premium services or data analytics offerings in the future. The market it operates in includes digital health, patient data management, and health information exchange. The platform enhances patient autonomy and facilitates better healthcare outcomes by providing a seamless way to manage and share health information.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2017
Headquarters
Redwood City, United States
Employees
12
Open positions
None listed
Dealroom signal
57.8/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Personal Health, Oncology, Patient Care, Hard Tech
Client focus
b2c

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Sep 2021 $325M $325M InVitae —
SERIES AEquity / VC Dec 2020 — — Schox Venture Capital —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Ciitizen website traffic

Latest recorded traffic for Ciitizen is 290 monthly website visits, up 61.1% over the last three months. Ciitizen's team declined 83.3% over the past year.

Latest monthly visits290 3-month web change+61.1% 1-year team growth-83.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Health CatalystTech platform that organizes and links health-related data from different systems and makes it available for all users South Jordan, United States Operational 1,412 $237M $195M
Daily RoundsDaily Rounds offers software solutions. The Company provides mobile application-based on healthcare services Bengaluru, India Acquired
HumaProvides a digital health platform used for predictive care and research London, United Kingdom Operational
TreatoIdentifies, aggregates and analyzes user-generated content from across the social health Web, to generate "patient voice"​ insights that help drive health-related decisions for patients and providers alike Yehud Monosson, Israel Operational
Omthera PharmaceuticalsDevelops therapies for patients with elevated triglyceride levels and increased risk of cardiovascular disease Princeton, United States Acquired
Multiplicom#Multiplicom is the leading Belgian biotech company that develops, manufactures and commercializes molecular diagnostic tests that enable personalized medicine Antwerp, Belgium Acquired
OrgenesisDeveloping and manufacturing cell-therapy solutions Tel Aviv-Yafo, Israel Operational
HelloBetterMaking mental health care universally accessible with 10 digital therapeutics, 6 PDTx/DiGA with universal reimbursement for 73m+ people in Germany, 33 clinical studies, Series A €17m Hamburg, Germany Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series A3 investors entered at this stage

Other known investors9 additional known investors

  • InVitae
  • Alaa Halawa
  • Ayman Alabdallah
  • Intermountain Ventures
  • Mubadala Capital
  • Mubadala Investment Company
  • Nickolas Mark
  • Spectrum Health Ventures
  • Wavemaker Three-Sixty Health
Team profiled 19 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States85.7%
🇪🇬 Egypt14.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ciitizen on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ciitizen’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.